| Description | SX-576 is undergoing further investigation as a potential therapy for pulmonary inflammation. It is also a potent non-competitive boronic acid-containing CXCR1/2 antagonists. |
| molecular weight | 466.21 |
| Molecular formula | C20H15BF4N2O4S |
| CAS | 1240494-14-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |